Literature DB >> 10461778

The different forms of neurofibromatosis.

M Ruggieri1.   

Abstract

In the last two decades our knowledge of the natural history, genetics and management of the different forms of neurofibromatosis has changed. Of the numerical classifications of neurofibromatosis proposed in the past, only neurofibromatosis type 1 (Nf1) and neurofibromatosis type 2 (Nf2) have been shown to be distinct at clinical and molecular levels. Mosaicism has been demonstrated both in patients with Nf1 and in patients with Nf2, and features of segmental or mosaic Nf1 and Nf2 have been defined. The outlying phenotypes and the molecular genetics of other, rarer, types of neurofibromatosis have been delineated: these are hereditary spinal neurofibromatosis, Schwannomatosis, familial intestinal neurofibromatosis, autosomal dominant "cafe-au-lait spots alone", autosomal dominant "neurofibromas alone", Watson syndrome, Noonan/neurofibromatosis syndrome and the so-called syndrome of multiple naevi, multiple schwannomas and multiple vaginal leiomyomas. In this article I will review the different forms of neurofibromatosis, focusing on those aspects that most commonly challenge the neurosurgeon.

Entities:  

Mesh:

Year:  1999        PMID: 10461778     DOI: 10.1007/s003810050398

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Ophthalmological manifestations in segmental neurofibromatosis type 1.

Authors:  M Ruggieri; P Pavone; A Polizzi; M Di Pietro; A Scuderi; A Gabriele; A Spalice; P Iannetti
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

2.  The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.

Authors:  Michael J Fisher; Sandip Basu; Eva Dombi; Jian Q Yu; Brigitte C Widemann; Avrum N Pollock; Avital Cnaan; Hongming Zhuang; Peter C Phillips; Abass Alavi
Journal:  J Neurooncol       Date:  2007-12-11       Impact factor: 4.130

Review 3.  Leiomyoma of the bladder in a patient with von Recklinghausen's neurofibromatosis.

Authors:  T L Däuth; M Conradie; R Chetty
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

4.  Neurofibromatosis type 1 and infantile spasms.

Authors:  Martino Ruggieri; Paola Iannetti; Maurizio Clementi; Agata Polizzi; Gemma Incorpora; Alberto Spalice; Piero Pavone; Andrea Domenico Praticò; Maurizio Elia; Anna Lia Gabriele; Romano Tenconi; Lorenzo Pavone
Journal:  Childs Nerv Syst       Date:  2008-09-19       Impact factor: 1.475

5.  Multiple schwannomas: report of two cases.

Authors:  V K Javalkar; T Pigott; P Pal; G Findlay
Journal:  Eur Spine J       Date:  2007-01-10       Impact factor: 3.134

6.  Options and strategies for hearing restoration in pediatric neurofibromatosis type 2.

Authors:  Hossein Mahboubi; William H Slattery; Gautam U Mehta; Gregory P Lekovic
Journal:  Childs Nerv Syst       Date:  2020-06-21       Impact factor: 1.475

7.  A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.

Authors:  Rosario Caltabiano; Gaetano Magro; Agata Polizzi; Andrea Domenico Praticò; Andrea Ortensi; Valerio D'Orazi; Andrea Panunzi; Pietro Milone; Luigi Maiolino; Francesco Nicita; Gabriele Lorenzo Capone; Roberta Sestini; Irene Paganini; Mariella Muglia; Sebastiano Cavallaro; Salvatore Lanzafame; Laura Papi; Martino Ruggieri
Journal:  Childs Nerv Syst       Date:  2017-04-01       Impact factor: 1.475

8.  Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.

Authors:  Urs Naber; Reinhard E Friedrich; Markus Glatzel; Victor Felix Mautner; Christian Hagel
Journal:  J Neurooncol       Date:  2010-09-07       Impact factor: 4.130

9.  Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.

Authors:  Marco Carotenuto; Maria Esposito
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

Review 10.  Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.

Authors:  Pamela L Wolters; Staci Martin; Vanessa L Merker; Kathy L Gardner; Cynthia M Hingtgen; James H Tonsgard; Elizabeth K Schorry; Andrea Baldwin
Journal:  Neurology       Date:  2013-11-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.